Is the association between optimistic cardiovascular risk perceptions and lower rates of cardiovascular disease

Robert Gramling1, Kathi L Heffner, William Mp Klein

  • 1Department of Family Medicine, University of Rochester, 1381 South Avenue, Rochester, NY 14620, USA. Robert_Gramling@URMC.Rochester.edu.

Biopsychosocial Medicine
|September 23, 2010
PubMed

Insights

Optimistic perceptions of cardiovascular disease risk in men are linked to lower death rates. This protective association is not explained by inflammation or endothelial dysfunction, suggesting a direct link between perception and health outcomes.

Area of Science:

  • Cardiovascular epidemiology
  • Psychosocial factors in health
  • Biomarkers of disease

Background:

  • Optimistic risk perception in men correlates with reduced cardiovascular mortality.
  • The underlying reasons for this association remain unclear, with potential for causality or confounding by unmeasured factors.
  • Inflammation and endothelial dysfunction are physiological processes implicated in cardiovascular disease.

Purpose of the Study:

  • To investigate if inflammation or endothelial dysfunction markers confound the link between cardiovascular disease risk perception and outcomes.
  • To elucidate the relationship between subjective risk assessment and objective cardiovascular health in men.

Main Methods:

  • A nested case-cohort study design was employed using data from the Pawtucket Heart Health Program.
  • C-reactive protein (CRP) and Vascular Endothelial Growth Factor (VEGF) levels were measured as biomarkers.
  • Stratified analyses and logistic regression modeled potential confounding effects.

Main Results:

  • Optimistic risk perception was associated with significantly lower odds of cardiovascular death (OR = 0.39).
  • Neither CRP nor VEGF levels confounded this observed association.
  • The findings indicate a robust link between perception and reduced mortality.

Conclusions:

  • The cardio-protective effect of optimistic cardiovascular disease risk perception in men is not attributable to baseline inflammation or endothelial dysfunction.
  • This suggests that psychological factors may play a direct role in cardiovascular health.
  • Further research may explore the mechanisms driving this perception-outcome relationship.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...